We are analyzing https://link.springer.com/article/10.1186/s12943-020-01238-x.

Title:
Natural killer cells in cancer biology and therapy | Molecular Cancer
Description:
The tumor microenvironment is highly complex, and immune escape is currently considered an important hallmark of cancer, largely contributing to tumor progression and metastasis. Named for their capability of killing target cells autonomously, natural killer (NK) cells serve as the main effector cells toward cancer in innate immunity and are highly heterogeneous in the microenvironment. Most current treatment options harnessing the tumor microenvironment focus on T cell-immunity, either by promoting activating signals or suppressing inhibitory ones. The limited success achieved by T cell immunotherapy highlights the importance of developing new-generation immunotherapeutics, for example utilizing previously ignored NK cells. Although tumors also evolve to resist NK cell-induced cytotoxicity, cytokine supplement, blockade of suppressive molecules and genetic engineering of NK cells may overcome such resistance with great promise in both solid and hematological malignancies. In this review, we summarized the fundamental characteristics and recent advances of NK cells within tumor immunometabolic microenvironment, and discussed potential application and limitations of emerging NK cell-based therapeutic strategies in the era of presicion medicine.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Health & Fitness
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cells, pubmed, google, scholar, cell, cas, cancer, central, killer, natural, tumor, immunol, human, immune, immunity, clinical, blood, function, receptor, receptors, expression, patients, cytotoxicity, activation, antitumor, therapy, innate, wang, nat, blockade, metabolic, tumors, breast, molecules, development, microenvironment, effects, res, clin, immunotherapy, response, activity, cytokine, inkt, including, treatment, activating, responses, functions, nkp,

Topics {✒️}

high-dimensional single-cell rna-seq il-15-responsive ifn-gamma-producing cells cytokine-inducible sh2-containg protein antibody-dependent cell-mediated cytotoxicity nk-mediated anti-tumor immunotherapy time-resolved single-cell assay t-cell-dependent tumor activity ifn-gamma-nonsecreting nk cells ic9/car-cd19/il-15 nk cells cd49a+cd56+cd3−cd19− nk cells zhi-ming shao generate natural-killer-cell diversity β-n-acetylhexosaminidase gm-cfs yi-zhou jiang natural killer-cell counts natural killer-mediated cytotoxicity long-lived nk cells monoclonal antibody-based immunotherapy natural killer-mediated lysis anti-pd-1/pd-l1 therapies transforming growth factor-β high-mobility group box 1 graft-versus-host responses b-cell lymphoblastic leukemia nk cell-mediated suppression myeloid-derived suppressor cells nk cell-based vaccines include tissue-resident nk recognizing b7-h6 expressed single-chain variable fragment nk cell-mediated killing nk cell-related immunotherapy single-cell transcriptome ananlysis paired single-cell analyses nk cell-based therapies cd3−cd16+cd56+ cells reflect inhibitory nkr-p1b receptor including fda-approved anti-ctla-4 lack mhc-i-related molecules hypoxia inducible factor-1α nk cell-based therapy anti-kir antibody iph2101 nk cell-based microenvironment enhances anti-tumor activity specific anti-tumor cytotoxicity nk cell-based immunity 27-hydroxycholesterol promotes cell-autonomous anti-pd-1 monoclonal antibody human cytokine-induced memory acute myelogenous leukemia/aml

Questions {❓}

A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to ?
Innate or adaptive immunity?
Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Natural killer cells in cancer biology and therapy
         description:The tumor microenvironment is highly complex, and immune escape is currently considered an important hallmark of cancer, largely contributing to tumor progression and metastasis. Named for their capability of killing target cells autonomously, natural killer (NK) cells serve as the main effector cells toward cancer in innate immunity and are highly heterogeneous in the microenvironment. Most current treatment options harnessing the tumor microenvironment focus on T cell-immunity, either by promoting activating signals or suppressing inhibitory ones. The limited success achieved by T cell immunotherapy highlights the importance of developing new-generation immunotherapeutics, for example utilizing previously ignored NK cells. Although tumors also evolve to resist NK cell-induced cytotoxicity, cytokine supplement, blockade of suppressive molecules and genetic engineering of NK cells may overcome such resistance with great promise in both solid and hematological malignancies. In this review, we summarized the fundamental characteristics and recent advances of NK cells within tumor immunometabolic microenvironment, and discussed potential application and limitations of emerging NK cell-based therapeutic strategies in the era of presicion medicine.
         datePublished:2020-08-06T00:00:00Z
         dateModified:2020-08-06T00:00:00Z
         pageStart:1
         pageEnd:26
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-020-01238-x
         keywords:
            Innate immunity
            Natural killer cell
            Tumor progression
            Immunometabolism
            Immunotherapy
            Precision treatment
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig4_HTML.png
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Song-Yang Wu
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tong Fu
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yi-Zhou Jiang
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Zhi-Ming Shao
               affiliation:
                     name:Fudan University Shanghai Cancer Center
                     address:
                        name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Fudan University
                     address:
                        name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Natural killer cells in cancer biology and therapy
      description:The tumor microenvironment is highly complex, and immune escape is currently considered an important hallmark of cancer, largely contributing to tumor progression and metastasis. Named for their capability of killing target cells autonomously, natural killer (NK) cells serve as the main effector cells toward cancer in innate immunity and are highly heterogeneous in the microenvironment. Most current treatment options harnessing the tumor microenvironment focus on T cell-immunity, either by promoting activating signals or suppressing inhibitory ones. The limited success achieved by T cell immunotherapy highlights the importance of developing new-generation immunotherapeutics, for example utilizing previously ignored NK cells. Although tumors also evolve to resist NK cell-induced cytotoxicity, cytokine supplement, blockade of suppressive molecules and genetic engineering of NK cells may overcome such resistance with great promise in both solid and hematological malignancies. In this review, we summarized the fundamental characteristics and recent advances of NK cells within tumor immunometabolic microenvironment, and discussed potential application and limitations of emerging NK cell-based therapeutic strategies in the era of presicion medicine.
      datePublished:2020-08-06T00:00:00Z
      dateModified:2020-08-06T00:00:00Z
      pageStart:1
      pageEnd:26
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-020-01238-x
      keywords:
         Innate immunity
         Natural killer cell
         Tumor progression
         Immunometabolism
         Immunotherapy
         Precision treatment
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01238-x/MediaObjects/12943_2020_1238_Fig4_HTML.png
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Song-Yang Wu
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tong Fu
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yi-Zhou Jiang
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Zhi-Ming Shao
            affiliation:
                  name:Fudan University Shanghai Cancer Center
                  address:
                     name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Fudan University
                  address:
                     name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:19
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University Shanghai Cancer Center
      address:
         name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Song-Yang Wu
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Tong Fu
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Yi-Zhou Jiang
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Zhi-Ming Shao
      affiliation:
            name:Fudan University Shanghai Cancer Center
            address:
               name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Fudan University
            address:
               name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
      name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
      name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China
      name:Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
      name:Department of Oncology, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University, Shanghai, China

External Links {🔗}(664)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.45s.

LINK . SPRINGER . COM {}